162537-11-3,
Methoxycarbonyl-L-tert-leucine,
N-Methoxycarbonyl-L-tert-leucine,
(S)-2-((Methoxycarbonyl)amino)-3,3-dimethylbutanoic acid,
n-(methoxycarbonyl)-l-tert-leucine,
(S)-N-(METHOXYCARBONYL)-TERT-LEUCINE,
Moc-L-tert-Leucine,
Methylcarbonyl-L-t-Leucine,
L-Valine, N-(methoxycarbonyl)-3-methyl-,
MFCD07778455,
N-(Methoxycarbonyl)-3-methyl-L-valine,
(S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoic acid,
(S)-2-Methoxycarbonylamino-3,3-dimethylbutyric acid,
(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanoic Acid,
N-Moc-L-tert-Leucine,
Methyl Carbonyl L-tert Leucine,
methoxycarbonyl-t-leucine,
SCHEMBL6418,
Atazanavir related compound A,
KSC498G3H,
CTK3J8333,
DTXSID80460466,
NWPRXAIYBULIEI-RXMQYKEDSA-N,
ACN-S003003,
ACT06799,
BCP04718,
CS-B0635,
N-methoxycarbonyl-(L)-tert-leucine,
N-Methoxycarbonyl-3-methyl-L-valine,
ANW-47952,
ZINC16698174,
AKOS010384614,
N-(methoxycarbonyl)-(L)-tert-leucine,
RL02087,
AC-23469,
AJ-69480,
AS-16159,
BC201469,
BR-60204,
S820,
SC-45140,
AB0018795,
AB1004607,
RT-004532,
ST2414564,
FT-0654624,
M-2427,
537M113,
I06-1304,
Q-102796,
(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoic acid,
Methoxycarbonyl-L-tert-leucine; (S)-2-Methoxycarbonylamino-3,3-dimethylbutyric acid,
MethylCarbonylL-tertLeucine,
C8H15NO4,
ACN-028482,
CID11263950,
BMS 214702-01,
EC 431-620-3,
(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoic Acid,